Transcription of NEW ZEALAND DATA SHEET - Medsafe
{{id}} {{{paragraph}}}
NEW ZEALAND DATA SHEET Page 1 of 10 1 PRODUCT NAME acetylcysteine 200 mg/mL Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION acetylcysteine 200 mg per mL (as N- acetylcysteine ) Each 10 mL ampoule contains 2 g N- acetylcysteine Excipients with known effect: Each 10ml of N- acetylcysteine for Infusion contains sodium. For full list of excipients, see 3 PHARMACEUTICAL FORM Concentrate for Infusion 4 CLINICAL PARTICULARS Therapeutic indications N- acetylcysteine is indicated for the treatment of paracetamol overdose in patients: who present within 15 hours after an acute overdose with a plasma paracetamol level on or above a line joining points of 150 mg/L at 4h and 20 mg/L at 15h (see nomogram below) or who have taken more than 200 mg/kg or 10 g (whichever is less) of sustained release paracetamol or have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150 mg/L at 4h and 20 mg/L at 15h (see nomogram below) or who have taken an acute overdose of paracetamol with opiates or medicines with anticholinergic effects and have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150 mg/L at 4h and 20 mg/L at 15h (see nomogram below) or where there is any
NEW ZEALAND DATA SHEET Page 1 of 10 1 PRODUCT NAME Acetylcysteine 200 mg/mL Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Acetylcysteine 200 mg per mL (as N-acetylcysteine)
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}